193 related articles for article (PubMed ID: 18482991)
21. TRPV1 modulates morphine-induced conditioned place preference via p38 MAPK in the nucleus accumbens.
Hong SI; Nguyen TL; Ma SX; Kim HC; Lee SY; Jang CG
Behav Brain Res; 2017 Sep; 334():26-33. PubMed ID: 28734766
[TBL] [Abstract][Full Text] [Related]
22. Protein kinase A anchoring via AKAP150 is essential for TRPV1 modulation by forskolin and prostaglandin E2 in mouse sensory neurons.
Schnizler K; Shutov LP; Van Kanegan MJ; Merrill MA; Nichols B; McKnight GS; Strack S; Hell JW; Usachev YM
J Neurosci; 2008 May; 28(19):4904-17. PubMed ID: 18463244
[TBL] [Abstract][Full Text] [Related]
23. Relative roles of protein kinase A and protein kinase C in modulation of transient receptor potential vanilloid type 1 receptor responsiveness in rat sensory neurons in vitro and peripheral nociceptors in vivo.
Varga A; Bölcskei K; Szöke E; Almási R; Czéh G; Szolcsányi J; Pethö G
Neuroscience; 2006 Jun; 140(2):645-57. PubMed ID: 16564637
[TBL] [Abstract][Full Text] [Related]
24. MAP kinase activation by mu opioid receptor involves phosphatidylinositol 3-kinase but not the cAMP/PKA pathway.
Ai W; Gong J; Yu L
FEBS Lett; 1999 Jul; 456(1):196-200. PubMed ID: 10452557
[TBL] [Abstract][Full Text] [Related]
25. Opioid peptide receptor studies. 16. Chronic morphine alters G-protein function in cells expressing the cloned mu opioid receptor.
Xu H; Lu YF; Rothman RB
Synapse; 2003 Jan; 47(1):1-9. PubMed ID: 12422367
[TBL] [Abstract][Full Text] [Related]
26. Modulation of transient receptor vanilloid 1 activity by transient receptor potential ankyrin 1.
Spahn V; Stein C; Zöllner C
Mol Pharmacol; 2014 Feb; 85(2):335-44. PubMed ID: 24275229
[TBL] [Abstract][Full Text] [Related]
27. Regulation of transient receptor potential channels of melastatin type 8 (TRPM8): effect of cAMP, cannabinoid CB(1) receptors and endovanilloids.
De Petrocellis L; Starowicz K; Moriello AS; Vivese M; Orlando P; Di Marzo V
Exp Cell Res; 2007 May; 313(9):1911-20. PubMed ID: 17428469
[TBL] [Abstract][Full Text] [Related]
28. The effects of recombinant rat mu-opioid receptor activation in CHO cells on phospholipase C, [Ca2+]i and adenylyl cyclase.
Smart D; Hirst RA; Hirota K; Grandy DK; Lambert DG
Br J Pharmacol; 1997 Mar; 120(6):1165-71. PubMed ID: 9134231
[TBL] [Abstract][Full Text] [Related]
29. Activation of mu opioid receptors sensitizes transient receptor potential vanilloid type 1 (TRPV1) via β-arrestin-2-mediated cross-talk.
Rowan MP; Bierbower SM; Eskander MA; Szteyn K; Por ED; Gomez R; Veldhuis N; Bunnett NW; Jeske NA
PLoS One; 2014; 9(4):e93688. PubMed ID: 24695785
[TBL] [Abstract][Full Text] [Related]
30. Chronic morphine-mediated adenylyl cyclase superactivation is attenuated by the Raf-1 inhibitor, GW5074.
Yue X; Varga EV; Stropova D; Vanderah TW; Yamamura HI; Roeske WR
Eur J Pharmacol; 2006 Jul; 540(1-3):57-9. PubMed ID: 16750187
[TBL] [Abstract][Full Text] [Related]
31. Chronic morphine increases GABA tone on serotonergic neurons of the dorsal raphe nucleus: association with an up-regulation of the cyclic AMP pathway.
Jolas T; Nestler EJ; Aghajanian GK
Neuroscience; 2000; 95(2):433-43. PubMed ID: 10658623
[TBL] [Abstract][Full Text] [Related]
32. Agonist-induced signaling and trafficking of the mu-opioid receptor: role of serine and threonine residues in the third cytoplasmic loop and C-terminal domain.
Capeyrou R; Riond J; Corbani M; Lepage JF; Bertin B; Emorine LJ
FEBS Lett; 1997 Sep; 415(2):200-5. PubMed ID: 9350996
[TBL] [Abstract][Full Text] [Related]
33. Evaluating Opioid-Mediated Adenylyl Cyclase Inhibition in Live Cells Using a BRET-Based Assay.
Manandhar P; Sachdev S; Santiago M
Methods Mol Biol; 2021; 2201():117-125. PubMed ID: 32975794
[TBL] [Abstract][Full Text] [Related]
34. TRPV1 receptor in expression of opioid-induced hyperalgesia.
Vardanyan A; Wang R; Vanderah TW; Ossipov MH; Lai J; Porreca F; King T
J Pain; 2009 Mar; 10(3):243-52. PubMed ID: 18774343
[TBL] [Abstract][Full Text] [Related]
35. Functional interaction between TRPV1 and mu-opioid receptors in the descending antinociceptive pathway activates glutamate transmission and induces analgesia.
Maione S; Starowicz K; Cristino L; Guida F; Palazzo E; Luongo L; Rossi F; Marabese I; de Novellis V; Di Marzo V
J Neurophysiol; 2009 May; 101(5):2411-22. PubMed ID: 19297510
[TBL] [Abstract][Full Text] [Related]
36. Ca2+ channel and adenylyl cyclase modulation by cloned mu-opioid receptors in GH3 cells.
Piros ET; Prather PL; Loh HH; Law PY; Evans CJ; Hales TG
Mol Pharmacol; 1995 May; 47(5):1041-9. PubMed ID: 7746271
[TBL] [Abstract][Full Text] [Related]
37. Distinct differences between morphine- and [D-Ala2,N-MePhe4,Gly-ol5]-enkephalin-mu-opioid receptor complexes demonstrated by cyclic AMP-dependent protein kinase phosphorylation.
Chakrabarti S; Law PY; Loh HH
J Neurochem; 1998 Jul; 71(1):231-9. PubMed ID: 9648870
[TBL] [Abstract][Full Text] [Related]
38. Protein kinase A maintains cellular tolerance to mu opioid receptor agonists in hypothalamic neurosecretory cells with chronic morphine treatment: convergence on a common pathway with estrogen in modulating mu opioid receptor/effector coupling.
Wagner EJ; Rønnekleiv OK; Kelly MJ
J Pharmacol Exp Ther; 1998 Jun; 285(3):1266-73. PubMed ID: 9618432
[TBL] [Abstract][Full Text] [Related]
39. Endogenous regulators of G protein signaling differentially modulate full and partial mu-opioid agonists at adenylyl cyclase as predicted by a collision coupling model.
Clark MJ; Linderman JJ; Traynor JR
Mol Pharmacol; 2008 May; 73(5):1538-48. PubMed ID: 18285510
[TBL] [Abstract][Full Text] [Related]
40. Modality-specific peripheral antinociceptive effects of μ-opioid agonists on heat and mechanical stimuli: Contribution of sigma-1 receptors.
Montilla-García Á; Perazzoli G; Tejada MÁ; González-Cano R; Sánchez-Fernández C; Cobos EJ; Baeyens JM
Neuropharmacology; 2018 Jun; 135():328-342. PubMed ID: 29580951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
